相关实验视频
Updated: Jan 10, 2026

12:19
Construction of an Affordable and Easy-to-Build Zebrafish Facility
Published on: November 22, 2014
17.0K
在水面上升之前:为基于能力的药房教育建立起杆
Denise H Rhoney1, Daniel J Schumacher2, Aleda M H Chen3
1University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.
American journal of pharmaceutical education
|November 22, 2025
概括
药房教育需要基于能力的药房教育 (CBPE) 作为解决当前压力的必要基础设施. 国家协调和投资对于实施这一至关重要的系统至关重要,以确保未来的专业相关性.
科学领域:
- 健康 职业 教育 教育 专业
- 药房实践 在药房实践.
- 教育改革教育改革的教育改革
背景情况:
- 药房教育面临重大挑战,包括过载的课程和培训与实践之间的脱节.
- 其他卫生专业正在采用协调,基于能力的转型,突出显示药学教育落后的风险.
- 现有的药房教育模式正面临压力,这表明需要进行系统性变革.
研究的目的:
- 提出基于能力的药学教育 (CBPE) 作为药学教育的必要结构框架.
- 倡导CBPE作为解决当前药房培训中的紧急漏洞的解决方案.
- 呼吁国家在实施CBPE方面保持一致和领导地位.
主要方法:
- 在医学和兽医教育方面,利用利益相关者知情的研究和国际先例.
- 适应"逃火"的比喻,以框架药房教育的危机.
- 利用范梅尔的五个组成部分的CBPE框架:结果能力,顺序的进展,量身定制的经验,专注于能力的指导和程序性评估.
主要成果:
- 基于能力的药学教育 (CBPE) 是一个有意识的,系统层面的结构,对于解决药学教育的弱点至关重要.
- CBPE的五个核心组成部分提供了一个有弹性的框架,以减轻与当前教育压力相关的风险.
- 早期采用CBPE元素是有希望的,但国家协调被认为是全面转型的关键.
结论:
- 基于能力的药学教育 (CBPE) 不仅仅是改革,而且是药学教育未来的重要基础设施.
- 需要采取紧急,协调的国家行动来实施CBPE并防止进一步侵蚀药学教育的价值.
- 对于CBPE的蓝图已经存在,需要集体投资和药房专业组织的领导.
相关概念视频
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
161
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
161
Clinically Relevant Drug Product Specifications: Methods of Establishment
189
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
189
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Pharmaceutical Equivalents
171
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
171
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K

